Skip to main content
Fig. 1 | Clinical Proteomics

Fig. 1

From: Highly sensitive therapeutic drug monitoring of infliximab in serum by targeted mass spectrometry in comparison to ELISA data

Fig. 1

Schematic structure of infliximab and its amino acid sequence depicting Fab heavy and light chains. Blue regions represent conserved peptide sequence, red shows unique amino acid sequences and green the hypervariable regions and interaction points with TNFa. The Peptide sequences selected for quantification are marked with bold and underlined

Back to article page

Clinical Proteomics

ISSN: 1559-0275